Funding for this research was provided by:
Cancer Council Queensland (1030336)
Institute of Health and Innovation, QUT
School of Biomedical Sciences at QUT
QUT RPA Scholarship
Australian Government RTP Scholarship
Cancer Australia (141222)
Received: 19 November 2020
Accepted: 13 October 2021
First Online: 10 January 2022
: All samples were collected with informed consent and institutional review board approval in accordance with the Declaration of Helsinki. The study has human ethics approval from the Mater Health Services Human Research Ethics Committee (HREC/15/MHS/127), UnitingCare Health Human Research Ethics Committee (1116), Queensland University of Technology (1500000169, 1500000323), and QIMR Berghofer (P3478, P2095).PDX establishment and passaging was performed according to animal ethics approvals at TRI (TRI/021/19) and QUT (1900000701). In vivo drug studies were performed according to animal ethics approvals at TRI and QUT (QUT/275/17 and 1700000755).
: Not applicable.
: OK has consulted for XING Technologies on development of diagnostic assays for HR deficiency. NW and JVP are co-founders and Board members of genomiQa. The other authors declare no competing financial interests. The remaining authors declare no competing interests.